Continuous Glucose Monitoring (CGM)

Therapy

What people using Continuous Glucose Monitoring (CGM) report

Every report comes from a Lived member, sent anonymously.

Have you tried Continuous Glucose Monitoring (CGM) for Type 2 Diabetes?

NameHow it went

About Continuous Glucose Monitoring (CGM)

How It Works

Continuous glucose monitoring (CGM) uses a small wearable sensor to estimate glucose (blood sugar) every few minutes, day and night. A thin filament sits just under the skin, usually on the back of the upper arm or the belly, and measures glucose in the fluid between cells. That level usually tracks blood glucose closely, with a short delay when glucose changes fast. Readings are sent wirelessly to a phone app, a handheld reader or an insulin pump. The value of CGM is less any single number than the pattern. A fingerstick meter shows glucose at one moment; a CGM shows whether it is rising or falling, how quickly, and what happened overnight or after a meal. Most devices display a trend arrow and can sound alarms when glucose goes too low or too high. Some can share readings with a family member, and some feed directly into an automated insulin delivery system, sometimes called an artificial pancreas, which adjusts insulin based on the sensor's readings.

Who It's For

CGM is mainly a tool for managing diabetes. The American Diabetes Association recommends it for anyone with diabetes who uses insulin, whether type 1, type 2 or another form, from diagnosis onward. It is also recommended for people taking other diabetes medicines that can cause low blood sugar, and it can help people on any diabetes treatment when the information would change how they manage it. Prescription systems such as the Dexcom G7 are cleared for children as young as 2. In pregnancy with type 1 diabetes, CGM helps people reach the tighter glucose goals pregnancy requires. CGM is particularly helpful for people who have frequent low blood sugar or who don't feel the usual warning symptoms of a low, because an alarm can catch it early. Some monitors, such as Dexcom's Stelo, are sold over the counter without a prescription. These are for adults who do not use insulin, including people with type 2 diabetes on oral medicines and people without diabetes who want to see how food and activity affect their glucose. Over-the-counter devices do not alert for low glucose, so they are not suitable for anyone at risk of dangerous lows.

What It Involves

Most sensors are applied at home with a small applicator that places the filament under the skin, which is usually only briefly uncomfortable. An adhesive patch holds the sensor in place, and it stays on through showers, exercise and sleep. Disposable sensors are replaced every 7 to 15 days depending on the model, and many need a short warm-up period before readings begin. A different option is an implantable sensor that a clinician places under the skin in a brief office procedure and that lasts for months. Prescription devices fall into a few types. Real-time CGMs, such as the Dexcom G7 and the FreeStyle Libre 3 Plus, send readings automatically and can sound alarms. Older scanning (flash) systems measure continuously but show readings only when the sensor is scanned. A professional CGM is worn for a week or two, often without the wearer seeing the numbers, so a clinician can review the pattern and adjust treatment. Using CGM well takes some setup: choosing alarm thresholds with the care team, learning to read trend arrows, and reviewing reports together at visits. A fingerstick meter is still needed as a backup.

What to Expect

Many people find the first weeks revealing, seeing for the first time how particular meals, exercise, stress or illness move their glucose. Getting comfortable with the device and its alarms can take days to months, and alarm thresholds often need adjusting to reduce unnecessary alerts without missing real ones. When a low or high alarm sounds, the response is to act on it promptly according to the treatment plan, which for a low usually means taking fast-acting sugar. CGM reports center on time in range: the share of the day glucose stays between 70 and 180 mg/dL (milligrams per deciliter). For most adults with type 1 or type 2 diabetes, a common goal is more than 70% of readings in that range, which is about 17 hours a day, while keeping time below 70 mg/dL to a minimum. Goals are less strict for older adults or people at high risk of lows, and the target range is tighter in pregnancy. Each 5% gain in time in range is linked with meaningful health benefits, so steady improvement matters even if the full goal is not reached. Clinicians still use the A1C blood test, which reflects average glucose over about three months, alongside CGM data.

What the Evidence Says

Randomized trials comparing real-time CGM with fingerstick testing show consistent benefits in both type 1 and type 2 diabetes. In a 2025 analysis of 64 trials, A1C fell by roughly a quarter of a percentage point more in type 1 diabetes and by about four-tenths of a point more in type 2 diabetes, and people spent about 80 more minutes a day in the target range. In type 1 diabetes, CGM also reduced time spent in low blood sugar. The benefits come mostly to people who wear the sensor every day or nearly every day. In pregnancy, CGM increased time in the pregnancy target range, but pooled trials did not show a clear improvement in A1C or in most outcomes for mother and baby, so its advantages there rest mainly on better day-to-day glucose control. For people without diabetes, the evidence is thin. A 2026 review found that seeing CGM data might support some dietary changes when combined with structured nutrition education, but large, lasting health benefits have not been shown, and evidence on effects like anxiety about food is too limited to judge.

Risks & Considerations

CGM is safe for most people, but its readings are estimates. Because it measures fluid between cells, it can lag behind blood glucose when levels are changing fast, such as after exercise or a meal. Keep a fingerstick meter available, and check with it before acting when readings don't match how you feel, during warm-up, or when the app shows no number or trend arrow. Some substances make readings falsely high. Hydroxyurea, a medicine used for some blood disorders and cancers, falsely raises readings on several CGM brands, and depending on the device, high doses of acetaminophen (Tylenol) or vitamin C supplements can too. Ask which ones apply to your model. Some sensors must come off before magnetic resonance imaging (MRI) or diathermy (a heat treatment used in some physical therapy) and must be kept out of the scanned area during a computed tomography (CT) scan. Labeling for other models differs, so tell the imaging or therapy team you are wearing one. Skin irritation or allergy to the adhesive is the most common problem. The care team can suggest techniques or medicines to manage it. Redness, swelling or pain at the insertion site can signal infection and is worth reporting to your care team. Cost is another practical factor: sensors are an ongoing expense, and insurance coverage varies. Finally, constant data can feel burdensome for some people; adjusting alarms and reviewing trends rather than every reading can help.

Questions to Ask Your Doctor

  1. 1.Would a real-time CGM with alarms, a professional CGM or an over-the-counter device fit my treatment and risk of low blood sugar?
  2. 2.What low and high alarm settings should I start with, and what should I do when each one goes off?
  3. 3.What time-in-range goal makes sense for me, and how will we review my CGM reports together?
  4. 4.Do any of my medicines or supplements interfere with readings on the device I would use?
  5. 5.Will my insurance cover the sensors, and what are the options if it doesn't?

Last reviewed • Oct 2026

Educational content, not medical advice.